Skip to main content

Table 2 Survival analysis demonstrating association between age, PSA, cT, GS and BSI at baseline

From: Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy

Variable at baseline N Hazard ratio pvalue
Univariate analysis    
Age 146 1.02 (0.99 to 1.05) 0.21
PSA 146 1.0002 (1.0000 to 1.0003) 0.02
cT 131 2.40 (1.43 to 4.04) 0.0009
GS 135 1.84 (1.38 to 2.46) <0.0001
BSI 146 1.27 (1.19 to 1.36) <0.0001
Multivariate analysis    
Age 121 1.02 (0.98 to 1.06) 0.28
PSA 121 0.9999 (0.9998 to 1.0002) 0.80
cT 121 2.20 (1.28 to 3.78) 0.004
GS 121 1.86 (1.34 to 2.58) 0.0002
Multivariate analysis    
Age 121 1.03 (0.99 to 1.06) 0.10
PSA 121 0.9999 (0.9997 to 1.0002) 0.58
cT 121 1.95 (1.16 to 3.28) 0.01
GS 121 1.99 (1.43 to 2.779) <0.0001
BSI 121 1.26 (1.16 to 1.37) <0.0001
  1. PSA, prostate-specific antigen; cT, clinical stage; GS, Gleason score; BSI,Bone Scan Index; N, number of patients.